NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $92,042,428 | +1.0% | 903,617 | +0.0% | 0.02% | +4.2% |
Q2 2023 | $91,146,251 | +9.7% | 903,243 | +0.0% | 0.02% | 0.0% |
Q1 2023 | $83,060,820 | -7.0% | 902,835 | -8.3% | 0.02% | -11.1% |
Q4 2022 | $89,305,494 | +19.4% | 984,408 | 0.0% | 0.03% | +8.0% |
Q3 2022 | $74,825,000 | -10.1% | 984,408 | -0.0% | 0.02% | -3.8% |
Q2 2022 | $83,241,000 | -3.7% | 984,751 | -0.0% | 0.03% | +23.8% |
Q1 2022 | $86,444,000 | +9.5% | 985,114 | +9.1% | 0.02% | +23.5% |
Q4 2021 | $78,955,000 | +6.9% | 902,656 | -0.0% | 0.02% | 0.0% |
Q3 2021 | $73,851,000 | -10.3% | 903,040 | +0.0% | 0.02% | -10.5% |
Q2 2021 | $82,364,000 | -59.3% | 902,720 | -61.8% | 0.02% | -61.2% |
Q1 2021 | $202,245,000 | -9.4% | 2,365,745 | +0.1% | 0.05% | -15.5% |
Q4 2020 | $223,164,000 | +34.5% | 2,363,280 | +23.9% | 0.06% | +16.0% |
Q3 2020 | $165,924,000 | +9.2% | 1,908,046 | +9.6% | 0.05% | +4.2% |
Q2 2020 | $152,009,000 | +6.1% | 1,740,433 | +0.1% | 0.05% | -14.3% |
Q1 2020 | $143,311,000 | -20.9% | 1,738,253 | -9.1% | 0.06% | +3.7% |
Q4 2019 | $181,106,000 | +9.2% | 1,912,635 | +0.2% | 0.05% | 0.0% |
Q3 2019 | $165,878,000 | -4.5% | 1,908,796 | +0.4% | 0.05% | -1.8% |
Q2 2019 | $173,681,000 | +16.5% | 1,902,109 | +22.7% | 0.06% | +17.0% |
Q1 2019 | $149,025,000 | +12.0% | 1,550,085 | +0.0% | 0.05% | +2.2% |
Q4 2018 | $133,013,000 | -0.4% | 1,550,084 | 0.0% | 0.05% | +17.9% |
Q3 2018 | $133,555,000 | +14.1% | 1,550,084 | -0.0% | 0.04% | +21.9% |
Q2 2018 | $117,094,000 | -6.6% | 1,550,087 | +0.0% | 0.03% | -11.1% |
Q1 2018 | $125,319,000 | -33.9% | 1,550,016 | -31.4% | 0.04% | -35.7% |
Q4 2017 | $189,625,000 | -2.2% | 2,258,515 | 0.0% | 0.06% | -5.1% |
Q3 2017 | $193,894,000 | +2.9% | 2,258,515 | +0.0% | 0.06% | 0.0% |
Q2 2017 | $188,517,000 | +12.4% | 2,258,505 | 0.0% | 0.06% | +11.3% |
Q1 2017 | $167,739,000 | +2.0% | 2,258,505 | +0.0% | 0.05% | 0.0% |
Q4 2016 | $164,509,000 | -7.8% | 2,258,500 | 0.0% | 0.05% | -10.2% |
Q3 2016 | $178,331,000 | -4.3% | 2,258,500 | 0.0% | 0.06% | -7.8% |
Q2 2016 | $186,349,000 | +13.9% | 2,258,500 | 0.0% | 0.06% | +14.3% |
Q1 2016 | $163,606,000 | -15.8% | 2,258,500 | 0.0% | 0.06% | -15.2% |
Q4 2015 | $194,321,000 | -6.4% | 2,258,500 | 0.0% | 0.07% | -10.8% |
Q3 2015 | $207,601,000 | -6.5% | 2,258,500 | 0.0% | 0.07% | +1.4% |
Q2 2015 | $222,101,000 | -0.3% | 2,258,500 | 0.0% | 0.07% | -3.9% |
Q1 2015 | $222,711,000 | -4.4% | 2,258,500 | -10.2% | 0.08% | -3.8% |
Q4 2014 | $233,045,000 | -1.6% | 2,515,056 | 0.0% | 0.08% | -3.7% |
Q3 2014 | $236,742,000 | +4.0% | 2,515,056 | 0.0% | 0.08% | +2.5% |
Q2 2014 | $227,688,000 | +9.0% | 2,515,056 | +2.4% | 0.08% | +6.7% |
Q1 2014 | $208,899,000 | +5.8% | 2,457,056 | 0.0% | 0.08% | +2.7% |
Q4 2013 | $197,498,000 | +4.8% | 2,457,056 | 0.0% | 0.07% | -1.4% |
Q3 2013 | $188,481,000 | +8.5% | 2,457,056 | 0.0% | 0.07% | 0.0% |
Q2 2013 | $173,738,000 | – | 2,457,056 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |